• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number SRGTWR-054030L
Device Problem Complete Blockage (1094)
Patient Problems Cardiopulmonary Arrest (1765); Death (1802); Unspecified Infection (1930)
Event Date 05/30/2017
Event Type  Death  
Manufacturer Narrative
The patient expired in (b)(6) 2017, but an exact date is unknown.Therefore, (b)(6) 2017 is determined to be the date of death.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore-tex® stretch vascular graft instructions for use (ifu), complications which may occur in conjunction with the use of any vascular prosthesis include but are not limited to infection and thrombosis.(b)(4).
 
Event Description
On (b)(6) 2017, the patient underwent norwood procedure to treat hypoplastic left heart syndrome (hlhs).During this procedure, a gore-tex® stretch vascular graft (srgtwr-054030l/(b)(4)) was used as a shunt between the right ventricle and the pulmonary artery.Also a clip was put on the shunt to control the amount of blood flow.On and around (b)(6) 2017 (21 days post initial procedure), the patient suffered from blood-stream infection.It was reported that catheters which had been put in the patient prior to the initial procedure could have caused or contributed to the blood-stream infection.On the same day, the patient received antimicrobial therapy.Approximately two weeks since the antimicrobial therapy had started, blood culture exam revealed that the patient was negative against infection.In (b)(6) 2017 (two months post initial procedure), the patient suffered from the blood-stream infection again.It was reported that a cause of infection was the same as the previous infection.The patient received the antimicrobial therapy.Also, computed tomography (ct) and echography were performed, revealing that the gore-tex® stretch vascular graft had not been thrombosed.In (b)(6) 2017 (three months post initial procedure), the patient was discharged.Later in follow-up studies, the patient was doing fine.In (b)(6) 2017 (four months post initial procedure), the patient got in cardio-pulmonary arrest and emergently admitted to the hospital.Resuscitation was not successful and the patient expired.It was reported that autopsy of the patient¿s heart was performed, confirming that a large amount of bacteria was present on pores of eptfe graft.Also, there was present a mass of bacteria inside the graft where it was clipped and narrowed, which could have caused thrombosis of the graft.Additionally, it was reported that the same bacteria was also found in the graft anastomosis site on the right ventricle.
 
Manufacturer Narrative
The review of the sterilization paperwork verified that this lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® STRETCH VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
yutaka uchiya
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7008511
MDR Text Key91287780
Report Number2017233-2017-00582
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K933943
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/19/2021
Device Catalogue NumberSRGTWR-054030L
Device Lot Number14987770
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/20/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Weight4
-
-